EPID-01. GLIOBLASTOMA TREATMENT OF BEVACIZUMAB ERA IN KANSAI REGION, JAPAN

Randomized trials failed to prove the efficacy of Bevacizumab on OS of newly diagnosed glioblastomas, but improvement of PFS was revealed. Based on these results, Japanese national health insurance approved Bevacizumab (Bev) for both primary and recurrent glioblastoma treatment in 2013. And at same...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Mori, Kanji, Shofuda, Tomoko, Okita, Yoshiko, Arita, Hideyuki, Kinoshita, Manabu, Terakawa, Yuzo, Tsuyuguchi, Naohiro, Tomogane, Yusuke, Fukai, Junya, Ishibashi, Kenichi, Nishida, Namiko, Taki, Takuyu, Nonaka, Masahiro, Izumoto, Shuichi, Moriuchi, Shusuke, Nakajima, Yoshikazu, Hashimoto, Naoya, Kodama, Yoshinori, Hirose, Takanori, Kanemura, Yonehiro
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693178/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.279
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker